Pages that link to "Q46406569"
Jump to navigation
Jump to search
The following pages link to Inhalation of insulin (Exubera) is associated with augmented disposal of portally infused glucose in dogs (Q46406569):
Displaying 8 items.
- Biologic comparison of inhaled insulin formulations: Exubera™ and novel spray-dried engineered particles of dextran-10. (Q34577401) (← links)
- Inhaled insulin is associated with prolonged enhancement of glucose disposal in muscle and liver in the canine (Q35453763) (← links)
- Diabetes therapy trials with inhaled insulin (Q36512554) (← links)
- Inhibition of dipeptidyl peptidase-4 by vildagliptin during glucagon-like Peptide 1 infusion increases liver glucose uptake in the conscious dog (Q42140416) (← links)
- Role of the hepatic sympathetic nerves in the regulation of net hepatic glucose uptake and the mediation of the portal glucose signal (Q46655006) (← links)
- Mealtime inhaled insulin lowers fasting glucose: a look at possible explanations. (Q46793351) (← links)
- Inhaled insulin (Q63977061) (← links)
- Contemporary formulation development for inhaled pharmaceuticals (Q99357052) (← links)